Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BRAF V600E-mutated metastatic Wilms tumor with complete response to targeted RAF/MEK inhibition: a post-treatment follow-up case report.
Journal: Frontiers in oncology
Published: February 27, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.
Journal: Cancers
Published: January 29, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.
Journal: Cancer research
Published: July 14, 2025
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.
Journal: Cancer research
Published: July 14, 2025
Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.
Journal: Molecular cancer therapeutics
Published: January 06, 2025
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Journal: Oncogene
Published: February 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026